Health Care Select Sector SPDR Fund (XLV)
| Assets | $37.44B |
| Expense Ratio | 0.10% |
| PE Ratio | 23.11 |
| Shares Out | n/a |
| Dividend (ttm) | $2.17 |
| Dividend Yield | 1.59% |
| Ex-Dividend Date | Dec 18, 2023 |
| Payout Ratio | 36.75% |
| 1-Year Return | +0.03% |
| Volume | 5,581,168 |
| Open | 136.24 |
| Previous Close | 136.24 |
| Day's Range | 135.83 - 136.62 |
| 52-Week Low | 122.59 |
| 52-Week High | 136.85 |
| Beta | n/a |
| Holdings | 66 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
54.21% of assets| Name | Symbol | Weight |
|---|---|---|
| UnitedHealth Group Incorporated | UNH | 9.60% |
| Eli Lilly and Company | LLY | 9.16% |
| Johnson & Johnson | JNJ | 7.45% |
| Merck & Co., Inc. | MRK | 5.45% |
| AbbVie Inc. | ABBV | 5.40% |
| Thermo Fisher Scientific Inc. | TMO | 4.07% |
| Abbott Laboratories | ABT | 3.79% |
| Pfizer Inc. | PFE | 3.21% |
| Amgen Inc. | AMGN | 3.05% |
| Danaher Corporation | DHR | 3.03% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2023 | $0.59773 | Dec 21, 2023 |
| Sep 18, 2023 | $0.53952 | Sep 21, 2023 |
| Jun 20, 2023 | $0.54244 | Jun 23, 2023 |
| Mar 20, 2023 | $0.48914 | Mar 23, 2023 |
| Dec 19, 2022 | $0.55613 | Dec 22, 2022 |
| Sep 19, 2022 | $0.50583 | Sep 22, 2022 |
News
Right now healthcare isn't showing any signs of turning around, says Truist's Keith Lerner
Keith Lerner, Truist co-chief investment officer and Bob Doll, Crossmark Global Investments chief investment officer, join 'Closing Bell Overtime' to talk the day's market action, their outlook for 20...
Biotech Stocks Are Rallying, but the Outlook Isn't Good
The XBI has been climbing this month. On Tuesday it jumped 5.4% to close at $70.91.
Chart Master: Sell healthcare, hold off on buying Pfizer
Carter Worth, Worth Charting, joins 'Fast Money' to talk his take on the healthcare space, Pfizer's recent performance and more.
Final Trades: Alphabet, NXP Semi & more
The "Halftime Report" traders give their top picks to watch for the second half.
The Bond Sell-Off Might Be Over. Buy These Stocks to Win.
Bond yields are showing signs that they have peaked. If they keep dropping, it would make a host of stocks look attractive including Duke Energy, Coca-Cola, Procter & Gamble, and Johnson & Johnson.
The Case For Healthcare Stocks
It stands to reason that investing in healthcare is less volatile than investing in other sectors. After all, people get sick in both good times and bad.
Fundamentals for M&A in healthcare sector remain really strong, says Guggenheim's Mehta
Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss d...
Final Trades: Uber, Energy & more
The "Halftime Report" traders give their top picks to watch for the second half.
Call of the day: The health care trade
CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.
CI Barrett's Amy Kong details her tech and healthcare stock playbook
Amy Kong, CI Barrett Asset Management CIO, joins 'Closing Bell' to discuss navigating the tech rally and health care names.
Healthcare sector should see a return to earnings growth next year, says Fort Pitt's Dan Eye
Dan Eye, Fort Pitt Capital Group CIO, joins 'Closing Bell OVertime' to discuss buying opportunities in the Healthcare sector and why he says the sector should see a return to earnings growth next year...
Final Trades: Lennar, Shake Shack, Health Care & more
The "Halftime Report" traders give their top picks to watch for the second half.
Recession concerns and defensive stock plays for investors to consider
Which stocks offer a defensive play in case of a recession? Jim Tierney, AB CIO of Concentrated U.S. Growth breaks down which industrial sectors are most poised to protect investors amid a volatile ec...
Healthcare Is Back. But Is It Here to Stay?
The economy, share price, and the pipeline for new drugs are three things for investors to think hard about.
Alger's Ankur Crawford names these as her under-the-radar stock picks
Ankur Crawford, Alger EVP, joins 'Closing Bell' to discuss under-the-radar stock picks.
Weekly Asset Flows: There's Gold in Those ETFs
Some of the best performing ETFs over the last week have been focused on commodities, but don't tell markets that; commodities ETFs saw the most outflows across the asset classes over the last week, w...
Health care notches record 8-week downtrend, but is it time to buy the dip?
Carter Worth of Worth Charting on whether health care is poised for a bounce. With CNBC's Melissa Lee and the Fast Money traders, Courtney Garcia, Karen Finerman, Dan Nathan and Guy Adami.
Healthcare Stocks Had a Strong 2022. It Isn't Too Late to Buy.
Profits in the sector tend to be stable even if hard times hurt earnings elsewhere, so the current high inflation and rising rates, represent a chance for the shares to shine.
Capital Wealth Planning founder Kevin Simpson breaks down his 5-star stock picks
Kevin Simpson, Capital Wealth Planning, joins 'Closing Bell: Overtime' to offer his five star playbook in energy, consumer staples and health care.
Health care stocks ‘hold up better than others' amid volatility, investor says
Columbia University Healthcare Policy Professor Meghan Fitzgerald joins Yahoo Finance Live to discuss the state of the health care industry, health care trends, labor supply shortages, how Telehealth ...
Jim Cramer explains healthcare stocks' strong performance this year
Cramer explained why healthcare stocks were able to perform well in this year's tumultuous market.
BlackRock Singles Out Health Care as Its ‘Largest Overweight' Position
Executives are bullish on the sector amid projected growth in innovation.